RecruitingPhase 3NCT05766670

Intramedullary Calcium Sulfate Antibiotic Depot

Intramedullary Calcium Sulfate Antibiotic Depot for Prevention of Open Fracture Related Infection: A Randomized Clinical Trial


Sponsor

Wake Forest University Health Sciences

Enrollment

497 participants

Start Date

Apr 8, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this randomized clinical trial is to study the best treatment for open lower leg fractures to prevent infection. The main questions it aims to answer is if treating tibia fracture patients with a calcium sulfate antibiotic depot is better at preventing infection that the standard of care.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether packing an antibiotic-containing calcium sulfate material into the bone canal (intramedullary space) at the time of surgical fracture repair reduces infection rates in patients with serious open tibia (shinbone) fractures. Open fractures — where the bone breaks through the skin — carry a high risk of infection because bacteria from the environment contaminate the wound at the time of injury. Traditional treatment involves systemic antibiotics, but local antibiotic delivery at the fracture site may provide superior protection. Adults 18 and older with a Type II or III open tibia fracture (significant soft tissue injury with exposed bone) requiring intramedullary nail fixation surgery are eligible. Patients with allergies to the antibiotics used (vancomycin or tobramycin), high calcium levels, those who speak neither English nor Spanish, pregnant or breastfeeding women, and prisoners are excluded. Infection after open fracture fixation is one of the most feared surgical complications — it can lead to bone infection (osteomyelitis), multiple surgeries, prolonged disability, and in severe cases, amputation. Local antibiotic depots could revolutionize fracture care for high-risk wounds, providing targeted, sustained antibiotic coverage right where it is needed most. This study could establish a new standard of care for a common and serious injury.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGVancomycin Hydrochloride

The intramedullary calcium sulfate antibiotic depot will be mixed sterilely to include at minimum 20cc calcium sulfate powder mixed with 1g of vancomycin powder and 1.2g of tobramycin powder per 10cc of calcium sulfate.

DRUGGentamicin

The intramedullary calcium sulfate antibiotic depot will be mixed sterilely to include at minimum 20cc calcium sulfate powder mixed with 1g of vancomycin powder and 1.2g of tobramycin powder per 10cc of calcium sulfate.

OTHERStandard Intramedullary Nail

Standard Intramedullary Nail


Locations(10)

Cedars-Sinai

Los Angeles, California, United States

Atrium Health Navicent The Medical Center

Macon, Georgia, United States

University of Kentucky

Lexington, Kentucky, United States

Louisiana State University Health Sciences Center

New Orleans, Louisiana, United States

Atrium Health Carolinas Medical Center

Charlotte, North Carolina, United States

Atrium Health Cabarrus

Concord, North Carolina, United States

Atrium Health Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, United States

Pennsylvania State University

Hershey, Pennsylvania, United States

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Valley Health

Winchester, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05766670


Related Trials